MBX
NASDAQ · Pharmaceuticals
Mbx Biosciences Inc
$27.82
-0.32 (-1.14%)
Open$27.96
Previous Close$28.14
Day High$28.45
Day Low$26.84
52W High$44.89
52W Low$4.81
Volume—
Avg Volume507.7K
Market Cap1.67B
P/E Ratio—
EPS$-3.39
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+69.4% upside
Current
$27.82
$27.82
Target
$47.13
$47.13
$32.34
$47.13 avg
$55.83
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 515.19M | 454.58M | 572.08M |
| Net Income | 92.27M | 88.31M | 111.14M |
| Profit Margin | 17.9% | 19.4% | 19.4% |
| EBITDA | 143.26M | 124.50M | 146.54M |
| Free Cash Flow | 88.64M | 54.29M | 70.53M |
| Rev Growth | +6.8% | +2.6% | +10.2% |
| Debt/Equity | 1.22 | 1.24 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |